A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma

Gabriel N. Waterman, Ori Yellin, Regina A. Swift, Russell Mapes, Benjamin Eades, Emily E. Ackerman, James R. Berenson

Annals of Hematology · 2010 · 18 citations · 32 references

Concepts

References

32